"Hank" proclaims that "Zicam will fail and fail miserably" simply because he says it didn't work for him. LMAO.
Here are some facts:
Zicam is much bigger than "Hank". You are only one person out of millions who buys remedies for the common cold each year and Zicam is now available in 40,000 to 50,000 locations.
The $2.5 billion common cold market is much bigger than "Hank".
Many more testimonials exist from people who say Zicam works than from those who say it doesn't work. Some possible explanations for this: everyone who said Zicam works is lying, you are lying, you didn't have a cold caused by a rhinoviral infection, you used it improperly, etc...
"Hank" has never had anything good to say about Gumtech or Zicam and there are many reasons to suspect that your account of Zicam wasn't conducted fairly or wasn't conducted at all. Of course people could claim the same about my account of Zicam since I'm long the stock, but the bottom line is that nobody has to take anyone's word for whether it works. They can use it themselves, or more importantly, wait for the results of the soon to be released independent clinical studies.
<GUMM is, always has been, and probably always will be a NET money LOSER.>
Irrespective of Zicam, you obviously haven't analyzed the effect that nicotine gum will probably have on the company's bottom line.
BTW, the stock is breaking out of its trading range and there's probably a good reason for it. Moves of this nature in most stocks generally precedes positive news. |
